Avi Dhariwal

PAPER Zheng W, Lin D, Shi S, Ren J, Wu J, Wang M, Wan S

Identifying shared diagnostic genes and mechanisms in vascular dementia and Alzheimer's disease via bioinformatics and machine learning.

J Alzheimers Dis Rep. 2024;8(1):1558-1572. Epub 2024 Nov 24 PubMed. Correction.

PAPER Noelker C, Seitz F, Sturn A, Neff F, Andrei-Selmer LC, Rau L, Geyer A, Ross JA, Bacher M, Dodel R

Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity.

J Autoimmun. 2025 Mar 3;152:103390. Epub 2025 Mar 3 PubMed.

PAPER Sabnam S, Kumar R, Pranav

Biofunctionalized nanomaterials for Parkinson's disease theranostics: potential for efficient PD biomarker detection and effective therapy.

Biomater Sci. 2025 Mar 4; Epub 2025 Mar 4 PubMed.

PAPER Leung KH, Chan VT, Lam BY, Mok VC, Cheung CY

Retinal vascular changes are associated with PET-based biomarkers of Alzheimer's disease: A pilot study.

J Alzheimers Dis Rep. 2024;8(1):1639-1648. Epub 2024 Dec 8 PubMed.

PAPER Chiang MT, Liu CJ, Lee BC, Yen RF, Tsai HH

Dual-Phase C-11 PiB PET Images for Detecting Tau Pathology in Cerebral Amyloid Angiopathy.

Ann Clin Transl Neurol. 2025 Mar 3; Epub 2025 Mar 3 PubMed.

PAPER Khowdiary MM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Elhenawy AA, Rashwan EK, Alexiou A, Papadakis M, Fetoh ME, Batiha GE

The Peripheral Amyloid-β Nexus: Connecting Alzheimer's Disease with Atherosclerosis through Shared Pathophysiological Mechanisms.

Neuromolecular Med. 2025 Mar 3;27(1):20. PubMed.

PAPER Abdelsalam SM, Matter AH, El-Hariri HM, Assaf AH, Khater MS, Tawfik HM

Adaptation and validation of the modified Egyptian Arabic version of Addenbrooke's Cognitive Examination III (VI-ACE-III) for assessing cognitive impairment in visually impaired elderly.

BMC Geriatr. 2025 Mar 4;25(1):145. PubMed.

PAPER Zhu Y, Wang A, Zhou Y, Yuan S, Ji Y, Hu W, Alzheimer’s disease Neuroimaging Initiative

Altered spatiotemporal consistency and their genetic mechanisms in mild cognitive impairment: a combined neuroimaging and transcriptome study.

Cereb Cortex. 2025 Feb 5;35(2) PubMed.

PAPER Gonzales MM, Fernandez R, Kremen S, Tan ZS, Werry AE, Jian X, Hart J, Royall D, Maestre G, Espinoza S, Seshadri S, Gelfond J, Wang CP

Predictors of bi-directional transitions from mild cognitive impairment in a diverse cohort.

J Gerontol A Biol Sci Med Sci. 2025 Feb 27; Epub 2025 Feb 27 PubMed.

PAPER de Rezende VL, de Aguiar da Costa M, Martins CD, Mathias K, Gonçalves CL, Barichello T, Petronilho F

Systemic Rejuvenating Interventions: Perspectives on Neuroinflammation and Blood-Brain Barrier Integrity.

Neurochem Res. 2025 Mar 4;50(2):112. PubMed.

PAPER Zhong YY, Deng JZ, Wang Q, Chen L, Yang ZH, Zhang YM, Zhou LY, Li YR, Wu JQ, Wang XQ

Development of novel melatonin-isatin hybrids as multifunctional agents for Alzheimer's disease.

Mol Divers. 2025 Mar 4; Epub 2025 Mar 4 PubMed.

PAPER Azargoonjahromi A, Alzheimer’s Disease Neuroimaging Initiative

Plasma tryptophan levels are linked to hippocampal integrity and cognitive function in individuals with mild cognitive impairment.

Brain Imaging Behav. 2025 Mar 4; Epub 2025 Mar 4 PubMed.

PAPER Kumar H, Datusalia AK, Kumar A, Khatik GL

Network pharmacology exploring the mechanistic role of indirubin phytoconstituent from Indigo naturalis targeting GSK-3β in Alzheimer's disease.

J Biomol Struct Dyn. 2025 Mar 4;:1-14. Epub 2025 Mar 4 PubMed.

PAPER Maazouzi M, Rasheed M, Mbarek L, Wang X, Liang J, Ma H, Chen Z, Deng Y

Exploring Non-Coding RNA Regulation of the Blood-Brain Barrier in Neurodegenerative Diseases: A Systematic Review.

J Neurochem. 2025 Mar;169(3):e70031. PubMed.